Prostate Cell News Volume 12.43 | Nov 12 2021

    0
    68







    2021-11-12 | PCN 12.43


    Prostate Cell News by STEMCELL Technologies
    Vol. 12.43 – 12 November, 2021
    TOP STORY

    Single-Cell Analysis Reveals EP4 as a Target for Restoring T Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy

    Investigators identified EP4 as a specific target for prostate cancer immunotherapy and demonstrated that YY001 inhibited the growth of prostate tumors by regulating the immune microenvironment and strongly synergized with anti-programmed cell death protein-1 antibodies.
    [Clinical Cancer Research]

    Abstract
    Subscribe to Organoid News to stay current with the latest organoid research.
    PUBLICATIONSRanked by the impact factor of the journal

    HER3 is an Actionable Target in Advanced Prostate Cancer

    The authors showed that membranous HER3 protein was commonly highly expressed in lethal prostate cancer, associating with reduced time to castration resistance and survival.
    [Cancer Research]

    Abstract

    Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen

    Scientists demonstrated the synthesis and initial biological assessment of prostate-specific membrane antigen-targeted, carborane-loaded prostate-specific membrane antigen-targeted poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles.
    [ACS Applied Materials & interfaces]

    AbstractGraphical Abstract

    Targeting KDM4A-AS1 Represses AR/AR-Vs Deubiquitination and Enhances Enzalutamide Response in CRPC

    Researchers reported KDM4A-AS1, a recently discovered lncRNA, as a tumor promoter that was significantly increased in CRPC cell lines and cancer tissues.
    [Oncogene]

    Full Article

    Continued Androgen Signaling Inhibition Improves Cabazitaxel Efficacy in Prostate Cancer

    The authors used the androgen receptor positive CRPC model PC346C-DCC-K to assess the in vitro and in vivo activity of combining enzalutamide with cabazitaxel.
    [Ebiomedicine]

    Full Article

    Anti-Metastatic Effect of GV1001 on Prostate Cancer Cells; Roles of GnRHR-Mediated Gαs-cAMP Pathway and AR-YAP1 Axis

    Investigators revealed the potential mechanisms by which GV1001-stimulated Gαs-cAMP signaling pathway reduced the migration and metastasis of prostate cancer cells.
    [Cell & Bioscience]

    Full Article

    MET Inhibition Enhances PARP Inhibitor Efficacy in Castration-Resistant Prostate Cancer by Suppressing the ATM/ATR and PI3K/AKT Pathways

    Researchers demonstrated that mesenchymal–epithelial transition (MET) inhibition enhanced sensitivity of CRPC to poly adenosine diphosphate–ribose polymerase (PARP) inhibitors by suppressing the ATM/ATR and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathways.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    ISL1 Promotes Enzalutamide Resistance in Castration-Resistant Prostate Cancer (CRPC) through Epithelial to Mesenchymal Transition (EMT)

    The authors revealed the important role of insulin gene enhancer-binding protein 1 (ISL1) in androgen receptor (AR)-dependent prostate cancer cell growth; ISL1 knockdown reduced the AR activity and cell growth.
    [Scientific Reports]

    Full Article

    Silencing Akt1 Enhances the Resistance of Prostate Cancer Cells to Starvation and Inhibits Starvation-Induced Lung Metastasis through Epithelial–Mesenchymal Transition in Prostate Cancer

    Scientists reported that although silencing Akt1 enhanced the invasion of prostate cancer (PCa) cells induced by nutritional starvation (NST) in vitro, silencing Akt1 inhibited the PCa lung metastasis induced by NST in vivo.
    [Medical Oncology]

    Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    Increasing the Value of PSA through Improved Implementation

    Investigators review how the value of prostate-specific antigen (PSA) could be improved by efficient implementation of smarter testing strategies that reduce the harms and increase the benefits.
    [Urologic Oncology-Seminars and Original investigations]

    Abstract

    Multiparametric Ultrasound and Micro-Ultrasound in Prostate Cancer: A Comprehensive Review

    The authors discuss recent advances in ultrasound with the goal to provide a readily accessible and cost-effective tool for detection of prostate cancer. Newer techniques include elastography and contrast-enhanced ultrasound, as well as improved B-mode and Doppler techniques.
    [British Journal of Radiology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

    Fluidigm Corporation announced that Imaging Mass Cytometryâ„¢ is being utilized in studies led by researchers at Weill Cornell Medicine to identify molecular links between African ancestry and aggressive forms of breast and prostate cancer and investigate these as a source of racial disparities in cancer outcomes.
    [Fluidigm Corporation]

    Press Release
    FEATURED EVENT

    Cell Bio Virtual 2021

    December 1 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Tenure Track Faculty Position – Cancer Research

    University of Maryland School of Medicine – Baltimore, Maryland, United States

    Postdoctoral Position – Epigenetic Reprogramming

    University of Freiburg – Freiburg, Germany

    Postdoctoral Fellowship – Cancer and Infections

    Lund University РMalm̦, Sweden

    Postdoctoral Research Associate – RNA Biology

    The University of British Columbia – Vancouver, British Columbia, Canada

    Postdoctoral Position – Cancer Biology

    Albert Einstein College of Medicine – Bronx, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter